- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04284527
The Assessment of Physiotherapy Practice Validation as a Measure in Physiotherapy Student (APP)
November 2, 2020 updated by: Jasemin Todri, Universidad Católica San Antonio de Murcia
Validity and Reliability of the Assessment of Physiotherapy Practice Validation as a Measure in Physiotherapy Student
The objective of this study is to determine the reliability and validity of the assesment of physiotherapy practice (APP) in physiotherapy students.
Concretely the study aims to verify if the APP created by the professors of specific methods of intervention in physiotherapy course is a reliable tool to evaluate student performance of history taking and physical examination in the same course.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Before evaluating this scale, the investigators want to verify the effectiveness of this online practice in the COVID period by processing the Mind Genomics questionnaire.
After the fist online results of this practice evaluation the investigators have to interpret and evaluate the APP.
Study Type
Observational
Enrollment (Actual)
300
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Murcia, Spain, 30107
- Universidad Católica de Murcia
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years to 39 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Students of the specific methods of intervention in physiotherapy course of Catholic University of Murcia, Spain
Description
Inclusion Criteria:
- students of specific methods of intervention in physiotherapy course
- students of Catholic University of Murcia, Spain
- with a minimum of 19 years old
- in the second course of physiotherapy
Exclusion Criteria:
- other courses participants
- professors
- segretary
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Assessment of Physiotherapy Practice (APP)
Time Frame: 10 minutes
|
Validity and reliability of the Assessment of Physiotherapy Practice tool with a total of 10 point valoration
|
10 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Carolina Vasques Villa, PhD, UCAM Universidad Catolica de Murcia
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 24, 2020
Primary Completion (Actual)
March 27, 2020
Study Completion (Actual)
June 4, 2020
Study Registration Dates
First Submitted
February 24, 2020
First Submitted That Met QC Criteria
February 24, 2020
First Posted (Actual)
February 25, 2020
Study Record Updates
Last Update Posted (Actual)
November 4, 2020
Last Update Submitted That Met QC Criteria
November 2, 2020
Last Verified
September 1, 2020
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 53383
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Assessment, Self
-
University Hospital Inselspital, BerneCompletedSelf-AssessmentSwitzerland
-
Istanbul University - Cerrahpasa (IUC)Not yet recruitingHealthy | Assessment, Self
-
Johannes Kepler University of LinzMedical University of GrazRecruiting
-
Johannes Kepler University of LinzMedical University of GrazCompleted
-
Technical University of MunichCharite University, Berlin, Germany; Translationales intensivmedizinisches...CompletedCritical Illness | Assessment, Self | Self-AssessmentGermany
-
AdventHealthUniversity of South Florida; Yale University; Beth Israel Deaconess Medical Center and other collaboratorsActive, not recruitingAssessment, Self | CompetenceUnited States
-
Istanbul University - Cerrahpasa (IUC)CompletedBody Image | Assessment, SelfTurkey
-
Lund UniversityCompletedCopd | Hospitalization | Assessment, SelfSweden
-
Wake Forest University Health SciencesCompletedSelf Geriatric Assessment Measure (SGAM)United States
Clinical Trials on Observational study
-
Taysha Gene Therapies, Inc.Withdrawn
-
AstraZenecaRecruitingNon-Small Cell Lung CancerUnited States
-
University of ManitobaCompletedObesity | Pregnancy | Cesarean SectionCanada
-
University of Castilla-La ManchaRecruitingKnee OsteoarthritisSpain
-
AstraZenecaRecruiting
-
Drexel UniversityCompletedOsteoporosisUnited States
-
The Aurum Institute NPCKarolinska Institutet; Ludwig-Maximilians - University of Munich; University... and other collaboratorsUnknownRespiratory Tract Infections | Tuberculosis, PulmonaryMozambique, South Africa, Tanzania, Gambia
-
Oslo University HospitalThe Research Council of NorwayRecruitingMesothelioma | Pseudomyxoma Peritonei | Colorectal Carcinoma | Ovarian CarcinomaNorway
-
Oslo University HospitalThe Research Council of NorwayActive, not recruiting
-
AstraZenecaDaiichi Sankyo, Inc.CompletedBreast CancerUnited States, Germany, Italy, Korea, Republic of, United Kingdom, Portugal, Australia, Japan, Canada, France